Last reviewed · How we verify

NCT04228029

Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids

Status unknown Phase 4 Last updated 14 January 2020
What this trial tests

Phase 4 trial testing Carboxytherapy in Alopecia Areata in 30 participants. Status unknown.

Timeline
20 August 2019
Primary endpoint
20 February 2020
20 April 2020

Quick facts

Lead sponsorKasr El Aini Hospital
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingdouble
Primary purposetreatment
Enrollment30
Start date20 August 2019
Primary completion20 February 2020
Estimated completion20 April 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 18 to 50, any sex, with Alopecia Areata. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with three lesions of alopecia areata are randomly recruited in this study. Each lesion is randomized in to receiving either carboxytherapy in one lesion, intralesional steroids in another lesion and combination of both in the third lesion. Treatment period is 3 months followed by a follow-up period of 2 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparative study for treatment of alopecia areata using carboxy therapy, intralesional corticosteroids, and a combination of both.
    Metwally D, Abdel-Fattah R, Hilal RF. · · 2022 · cited 7× · PMID 33742252 · DOI 10.1007/s00403-021-02201-6

Verify or expand the search:

Other trials of Carboxytherapy

Trials testing the same drug.

Other recruiting trials for Alopecia Areata

Currently open trials in the same condition.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04228029.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing